Presentation Open Access

HDSA Convention Presentation: From proteins to people: understanding Huntington's disease at the molecular level

Harding, Rachel

Presentation at HDSA Convention 2019 in Boston in "Moving Beyond Mice: Understanding HD in People" session.

Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (29.3 MB)
Name Size
HDSA_convention_RHarding_2019.pdf
md5:77c80a88d099f346fb53c9c437b1e730
29.3 MB Download
24
16
views
downloads
All versions This version
Views 2424
Downloads 1616
Data volume 468.3 MB468.3 MB
Unique views 1919
Unique downloads 1212

Share

Cite as